Article info
PDFCase Reports: Learning from unexpected outcome (positive or negative)
A rare and complete response to combination therapy with radiation and nivolumab in a patient with metastatic urothelial cancer
- Correspondence to Dr Matti Säily; matti.saily{at}lshp.fi
Citation
A rare and complete response to combination therapy with radiation and nivolumab in a patient with metastatic urothelial cancer
Publication history
- Accepted April 5, 2022
- First published May 17, 2022.
Online issue publication
May 17, 2022
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© BMJ Publishing Group Limited 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.